Video

Dr. Kumar on Defining Multiple Myeloma

Shaji Kumar, MD, professor of Medicine, Mayo Clinic, gives an overview on the expanded definition of multiple myeloma.

Shaji Kumar, MD, professor of Medicine, Mayo Clinic, gives an overview on the expanded definition of multiple myeloma.

Multiple myeloma that requires treatment, Kumar explains, is when organ damage such as high calcium, bone disease, anemia, and/or kidney issues occur. However, the definition of multiple myeloma has been expanded to include biomarkers that predict for development of these characteristics. It has also been expanded to include patients who have more than 60% of plasma cells in their bone marrow, have a free light chain ratio of more than 100, or have one or more lesions found on MRI or PET scans.

Researchers have determined that among patients who harbor one of these characteristics, the risk of having symptomatic or active multiple myeloma in 2 years is over 80%. Thus, it may be more beneficial to treat these patients earlier, Kumar says.

Related Videos
James J. Harding, MD, associate attending physician, Memorial Sloan Kettering Cancer Center
J. Bradley Elder, MD
Rimas V. Lukas, MD
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Shubham Pant, MD, MBBS
Kevin Kalinsky, MD, MS, professor, Department of Hematology and Medical Oncology, director, Division of Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine; Louisa and Rand Glenn Family Chair in Breast Cancer Research, director, Glenn Family Breast Center, director, Breast Medical Oncology, Winship Cancer Institute of Emory University
Brett L. Ecker, MD
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center